Lucian Marts
Overview
Dr. Marts is a native of Atlanta, GA and completed his undergraduate degree at the University of Georgia. He subsequently moved to Augusta, GA where he completed his medical degree at the Medical College of Georgia. He then went on to Boston, MA where he completed an internal medicine residency at Beth Israel Deaconess Medical Center, and braved the fierce Boston winters. The sunny Georgia weather continued to call to him, so he moved back to Atlanta where he completed his fellowship in pulmonary and critical care medicine at Emory University. It was here that under the guidance of Drs. David Guidot and Viranuj Sueblinvong, Lucian performed basic science research aimed at identifying the mechanism by which chronic HIV infection and alcohol use promote lung fibrosis. Dr. Marts joined the Emory faculty in 2018 as an assistant professor of medicine. His work is divided between Grady Memorial Hospital, Emory University Hospital Midtown, and Emory University Hospital with a specific clinical interest in rare and orphan lung diseases, sarcoidosis, and interstitial lung disease. He has a translational research focus on sarcoidosis, idiopathic pulmonary fibrosis, and connective tissue disease-related interstitial lung disease. In addition to his clinical and research work he has the opportunity to teach medical students, residents, and fellows in the inpatient and outpatient settings.
Academic Appointment
- Assistant Professor, Medicine, Emory University SOM
Education
Degrees
- MD from Medical College of Georgia
- BS Microbiology from University of Georgia
Research
Publications
-
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
Arthritis Rheumatol Volume: 77 Page(s): 477 - 489
04/01/2025 Authors: Faghihi-Kashani S; Yoshida A; Bozan F; Zanframundo G; Rozza D; Loganathan A; Dourado E; Sambataro G; Bauer-Ventura I; Bae SS -
A pilot metabolomics study across the continuum of interstitial lung disease fibrosis severity.
Physiol Rep Volume: 12 Page(s): e70093
10/01/2024 Authors: Zhan J; Jarrell ZR; Hu X; Weinberg J; Orr M; Marts L; Jones DP; Go Y-M -
Use of Additional Corticosteroids in Nonresolving COVID-19-Associated Acute Respiratory Distress Syndrome: A Resolved Issue?
Crit Care Med Volume: 51 Page(s): 1434 - 1436
10/01/2023 Authors: Marts LT; Kang M -
Efzofitimod for the Treatment of Pulmonary Sarcoidosis.
Chest Volume: 163 Page(s): 881 - 890
04/01/2023 Authors: Culver DA; Aryal S; Barney J; Hsia CCW; James WE; Maier LA; Marts LT; Obi ON; Sporn PHS; Sweiss NJ -
Perceived Hospital Stress, Severe Acute Respiratory Syndrome Coronavirus 2 Activity, and Care Process Temporal Variance During the COVID-19 Pandemic.
Crit Care Med Volume: 51 Page(s): 445 - 459
04/01/2023 Authors: Anesi GL; Andrews A; Bai HJ; Bhatraju PK; Brett-Major DM; Broadhurst MJ; Campbell ES; Cobb JP; Gonzalez M; Homami S -
Study on the relationship between selenium and cadmium in diseased human lungs.
Adv Redox Res Volume: 7
04/01/2023 Authors: Smith MR; Hu X; Jarrell ZR; He X; Orr M; Fernandes J; Chandler JD; Walker DI; Esper A; Marts L -
Vanadium pentoxide induced oxidative stress and cellular senescence in human lung fibroblasts.
Redox Biol Volume: 55 Page(s): 102409
09/01/2022 Authors: He X; Jarrell ZR; Liang Y; Ryan Smith M; Orr ML; Marts L; Go Y-M; Jones DP -
Safety and Efficacy ATYR1923, a Novel Immunomodulator for Pulmonary Sarcoidosis: Results of a Phase 1b/2a Randomized Placebo-Controlled Trial
Volume: 205
05/01/2022 Authors: Sporn PH; Culver DA; Barney J; Maier LA; James WE; Hsia CCW; Sweiss NJ; Aryal S; Obi ON; Tabassomi M -
Minimal clinically important difference in idiopathic pulmonary fibrosis.
Breathe (Sheff) Volume: 17 Page(s): 200345
06/01/2021 Authors: Kang M; Marts L; Kempker JA; Veeraraghavan S -
PULMONARY LANGERHANS'-CELL HISTIOCYTOSIS AND ADENOCARCINOMA: WHO'S WHO?
Volume: 158 Page(s): 1381A - 1382A
10/01/2020 Authors: Wigger G; Flenaugh E; Oprea-Ilies G; Kempker J; Marts L